Teva Pharmaceutical will pay over $4 billion in opioid settlement in case heard in Cleveland | Crain's Cleveland Business
PRIOR AUTHORIZATION POLICY Opioids – Fentanyl Transmucosal Drugs Prior Authorization Policy • Abstral ® (fentanyl sublingua
PRIOR AUTHORIZATION CRITERIA
Teva fueled opioid addiction in New York state, jury finds | Business and Economy News | Al Jazeera
Actiq: Package Insert / Prescribing Information - Drugs.com
Actiq: Package Insert / Prescribing Information - Drugs.com
Teva Launches Generic Actiq Lozenges - MPR
Cephalon sales rep tells court Actiq, Fentora opioids were not viable sellers in W.Va. | West Virginia Record
Actiq 400 micrograms Lozenges - Summary of Product Characteristics (SmPC) - (emc)
Opiod manufacturer Teva agrees to $4.25 billion settlement
ACT-40031 ACTIQ PI MG and IFU DIGITAL 11-2022 v2.indd
Teva Pharmaceuticals Found Liable For Opioid Crisis by Jury, Trial Will Determine Penalty
Actiq 600 micrograms Lozenges - Summary of Product Characteristics (SmPC) - print friendly - (emc)
Teva Pharmaceutical Industries Limited (TEVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile | PDF | Initial Public Offering | Pharmaceutical Industry
New York jury holds drugmaker Teva liable in opioid crisis | WFXRtv
FOI 1299 document 95
Medication Guide
Actiq (fentanyl citrate) Drug / Medicine Information
Suit: Drugmaker Teva responsible for patient's death in opioid overdose
Teva launches generic Actiq | Drug Store News
Reference ID: 4028203
NYSDFS Enforcement Action - August 18, 2020: Statement of Charges and Notice of Hearing regarding Teva Pharmaceutical Industries
UPDATED: Teva goes for the absurd in latest opioid addiction video series | Fierce Pharma
These highlights do not include all the information needed to use ACTIQ safely and effectively. See full prescribing information for ACTIQ. ACTIQ® (fentanyl citrate) oral transmucosal lozenge, CII Initial U.S. Approval: 1968
